There are 702 resources available
Treatment of MSS colon cancer first- line, maintenance: Current and future options, future
Presenter: Chiara Cremolini
Session: Metastatic colon cancer
Resources:
Slides
Webcast
Therapeutic vaccines in GI cancers
Presenter: Luigi Buonaguro
Session: New targets in immunotherapy beyond CTL4 and PD(L)1
Resources:
Slides
Webcast
BRAF mutations and metastatic colon cancer
Presenter: Dominik Modest
Session: Metastatic colon cancer
Resources:
Slides
Webcast
Cellular therapies in the treatment of GI cancer
Presenter: Kohei Shitara
Session: New targets in immunotherapy beyond CTL4 and PD(L)1
Resources:
Slides
Webcast
New targets in metastatic colon cancer
Presenter: Josep Tabernero
Session: Metastatic colon cancer
Resources:
Slides
Webcast
Q&A
Session: New targets in immunotherapy beyond CTL4 and PD(L)1
Resources:
Webcast
Q&A
Session: Metastatic colon cancer
Resources:
Webcast
Interim analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (RC)
Presenter: Francesco Sclafani
Session: Mini Oral Session 2
Resources:
Slides
Webcast
Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate: A proof of concept study - Preliminary results of FFCD 1703 POCHI trial
Presenter: David Tougeron
Session: Mini Oral Session 2
Resources:
Slides
Webcast
LBA2 - Interim analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (RC)
Presenter: Francesco Sclafani
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast